Truist Financial Corp Acadia Pharmaceuticals Inc Transaction History

Truist Financial Corp

$65.3 Billion
Q1 2024

A detailed history of Truist Financial Corp transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Truist Financial Corp holds 43,119 shares of ACAD stock, worth $700,683. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,119

Previous 63,926 32.55%

Holding current value

$700,683

Previous $2 Million 60.17%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$17.79 - $30.86 $370,156 - $642,104	-20,807 Reduced 32.55%	43,119 $797,000
Q4 2023 Feb 02, 2024	SELL	$20.78 - $31.77 $682,082 - $1.04 Million	-32,824 Reduced 33.93%	63,926 $2 Million
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $668,297 - $1.07 Million	32,068 Added 49.58%	96,750 $2.02 Million
Q2 2023 Aug 01, 2023	BUY	$17.8 - $25.65 $362,354 - $522,157	20,357 Added 45.93%	64,682 $1.55 Million
Q1 2023 May 05, 2023	BUY	$16.32 - $20.92 $106,716 - $136,795	6,539 Added 17.31%	44,325 $834,000

Q4 2022 Feb 17, 2023	SELL	$14.2 - $18.63 $57,964 - $76,047	-4,082 Reduced 9.75%	37,786 $601,000
Q3 2022 Oct 26, 2022	SELL	$14.11 - $18.27 $106,008 - $137,262	-7,513 Reduced 15.21%	41,868 $685,000
Q2 2022 Jul 22, 2022	SELL	$13.01 - $27.22 $156,328 - $327,075	-12,016 Reduced 19.57%	49,381 $696,000
Q1 2022 Apr 22, 2022	SELL	$20.94 - $27.5 $436,829 - $573,677	-20,861 Reduced 25.36%	61,397 $1.49 Million
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $365,048 - $588,990	-21,742 Reduced 20.91%	82,258 $1.92 Million
Q3 2021 Nov 05, 2021	BUY	$15.78 - $24.77 $267,833 - $420,421	16,973 Added 19.5%	104,000 $1.73 Million
Q2 2021 Aug 16, 2021	BUY	$19.4 - $27.42 $220,965 - $312,313	11,390 Added 15.06%	87,027 $2.12 Million
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $823,433 - $1.81 Million	32,911 Added 77.03%	75,637 $1.95 Million
Q4 2020 Nov 19, 2021	SELL	$41.04 - $56.79 $164,077 - $227,046	-3,998 Reduced 8.56%	42,726 $2.28 Million
Q4 2020 Feb 18, 2021	BUY	$41.04 - $56.79 $712,290 - $985,647	17,356 Added 59.1%	46,724 $2.5 Million
Q3 2020 Nov 13, 2020	BUY	$36.42 - $57.0 $473,532 - $741,114	13,002 Added 79.45%	29,368 $1.21 Million
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $80,640 - $108,307	2,054 Added 14.35%	16,366 $793,000
Q1 2020 May 15, 2020	BUY	$31.65 - $46.87 $38,328 - $56,759	1,211 Added 9.24%	14,312 $605,000
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $474,387 - $673,391	13,101 New	13,101 $561,000
Q4 2017 Jan 29, 2018	SELL	$26.84 - $39.14 $156,638 - $228,421	-5,836 Closed	0 $0
Q3 2017 Oct 23, 2017	BUY	$29.49 - $38.37 $172,103 - $223,927	5,836	5,836 $220,000

Others Institutions Holding ACAD

# of Institutions

299

Shares Held

158M

Call Options Held

1.88M

Put Options Held

688K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account

Truist Financial Corp Acadia Pharmaceuticals Inc Transaction History